University of Mississippi

eGrove
Electronic Theses and Dissertations

Graduate School

2018

Polymer Based Delivery Of Doxycycline Hyclate For The
Prevention Of Peri-Implant Mucositis Infection
Sagar Deepak Sawant
University of Mississippi

Follow this and additional works at: https://egrove.olemiss.edu/etd
Part of the Pharmacy and Pharmaceutical Sciences Commons

Recommended Citation
Sawant, Sagar Deepak, "Polymer Based Delivery Of Doxycycline Hyclate For The Prevention Of PeriImplant Mucositis Infection" (2018). Electronic Theses and Dissertations. 726.
https://egrove.olemiss.edu/etd/726

This Thesis is brought to you for free and open access by the Graduate School at eGrove. It has been accepted for
inclusion in Electronic Theses and Dissertations by an authorized administrator of eGrove. For more information,
please contact egrove@olemiss.edu.

POLYMER BASED DELIVERY OF DOXYCYCLINE HYCLATE FOR THE PREVENTION
OF PERI-IMPLANT MUCOSITIS INFECTION

A thesis
presented in partial fulfilment of requirements
for the degree of Master of Science
in the Department of Pharmaceutics & Drug Delivery
The University of Mississippi

by,
SAGAR SAWANT,
May 2018

Copyright Sagar Sawant 2018
ALL RIGHTS RESERVED

ABSTRACT
Peri-implant mucositis is a silent inflammatory condition that is destructive in nature
affecting only the soft tissues in the vicinity of dental implants. The current line of treatment
includes the use of systemic antibiotics, mechanical debridement using LASER decontamination,
the use of mouthwash or oral rinsing with chlorhexidine, maintenance and improvement of oral
hygiene, mechanical debridement with or without systemic antibiotic treatment, mechanical
debridement with or without the use of local drug delivery systems. However, these treatments do
not solve the problem of implant rejection as peri-implant mucositis progresses to per-implantitis
which causes severe bone loss and ultimately leading to implant rejection thus causing a great
amount of inconvenience to the patient leading to a reduction in patient compliance. Local
delivery of doxycycline may decrease the systemic toxicity of the drug and can also save time
and money for the patient in the long run. The aim of my study is to formulate and characterize
the release of doxycycline from the polymer matrix and also to reduce the systemic toxicity of
doxycycline owing to the localized nature of the formulation. To achieve this goal, the titanium
implants were coated in layer by layer fashion using an alternate combination of Hyaluronic acid
and Chitosan to get a controlled release of doxycycline over a two-week period. The objective of
my study was to develop layer by layer antibacterial coatings based on the principle of ionic
gelation over the surface of titanium implants loaded with doxycycline using chitosan,
hyaluronic acid, polycaprolactone Poly-lactic glycolic acid based on a layer by layer selfassembly technique for the prevention of periodontal infections.
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CHAPTER 1
INTRODUCTION

1

Dental implants for the past several decades have been used as a Gold Standard for the
replacement of missing tooth1. Basically, two types of implants are available in the market one is
made primarily of titanium whereas the other is made up of zirconium. Apart of titanium and
zirconium, a number of other elements too are present in the dental implants with each serving a
specific purpose. Aluminum incorporated into dental implants reduces the specific weight of the
dental implant. Vanadium present decreases the thermal conductivity of the implants. Zirconiumbased implants are white in color whereas titanium-based implants are grey in color2,3. This makes
zirconium aesthetically and cosmetically more acceptable than titanium. In spite of these cosmetic
drawbacks, titanium has been a material of choice for the manufacture of dental implants owing
to its biocompatibility with human tissue coupled with great mechanical properties4. Apart of
titanium and zirconium, a number of other elements too are present in the dental implants with
each serving a specific purpose. Aluminum incorporated into dental implants reduces the specific
weight of the dental implant. Vanadium present decreases the thermal conductivity of the implants.
Even with a success rate of about 90%, there still have been instances of peri-implant mucositis
infections in a number of patients5. The infection around the implant is primarily due to gramnegative anaerobic bacteria which ultimately leads to implant rejection and the resulting
complications

5,6

. In order to address this issue, a number of therapeutic avenues are available

which include surgical removal of the tissue, treatment with anti-biotic and laser therapy against
potential pathogens to facilitate the re-osseointegeration of the implant and thus ensure the
success of the therapy6. The bacterial adhesion on the surface of implant followed by biofilm
formation is the root cause of implant rejection by the patient. The presence of biofilm renders
any treatment with antimicrobials or even by hosts’ defenses mechanism fruitless as the biofilm
is a self-sustained in its nutrition and blood supply3,7. In spite of strict laboratory procedures like
2

strict surgical sterile protocols to eradicate the instance of implant rejection due to bacteria which
are already present in the oral environment. The route through which the bacteria attaches itself
to the surface of the implant is from the soft and hard tissue of the gum cavity8.It is this surface of
the dental implant which has to be coated with a layer by layer coat of individual polymers as it is
susceptible to bacterial attachment and consequently leading to biofilm formation9. Inhibition of
initial bacterial adhesion over the surface of the dental implant is one of the best ways of
preventing biofilm formation3,9. My research focusses primarily on preventing bacterial adhesion
and further biofilm formation through the principle of ionic gelation of oppositely charged
polymers loaded with doxycycline in a layer by layer fashion for sustained drug delivery.

A-1 Etiology of Peri-implant mucositis:
This condition is characterized as a site specific10 inflammatory destruction of only the
soft and surrounding the dental implants11. Peri-implant mucositis and peri-implantitis are
associated terms which are closely related to each other but the impact they have on the
supporting bone is different. Peri-implantitis causes considerable loss of horizontal and vertical
bone with various signs and occurs after osseointegeration has been achieved whereas periimplant mucositis gives no signs of loss of supporting bone12. Many efforts have been made to
understand the pathophysiology of the disease but the exact cause has not been identified. A
number of associated factors like poor oral hygiene, smoking, diabetes are known to be
implicated in periodontal and peri-implant infection12,13. Patients suffering from peri-implant
mucositis are more prone to suffer from, failure of implant therapy, reduced compliance, extra
costs, discomfort

13–15

associated with it

. Spirochetes and other gram-negative anaerobes are known to be

10

. These gram-negative anaerobes include Prevotella intermedia,
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Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Bacteroides forsythus,
Treponema denticola, Prevotella nigrescens, Peptostreptococcus micros, and Fusobacterium
nucleatum

10,16

. These micro-organisms are sensitive to doxycycline hyclate in vitro at a

concentration of ≤10µg/ml17.Interleukin levels too are elevated in patients suffering from perimucositis5. Interleukin-10 has been observed in high concentrations in peri-implant mucositis
patients5, higher levels of IL-1 and IL-6 too have been observed which are thought to be
implicated in tissue destruction5,18.Inadequate distribution of pressure on the tissue surrounding
the implants has also been implicated with peri-implant mucositis10,19. Osseointegration is used
as a quantitative and qualitative yardstick to evaluate the success of implant therapy 10.
A-2 Management of Peri- implant mucositis:
The goal of current peri-implant mucositis treatment is to ensure successful
osseointegration of the implant into the oral cavity and to prevent the incidence of microbial
infection that is associated with it. Oral hygiene is a key to the success of implant-based therapy
coupled with following good healthy habits. Even before the implant therapy is started, the
patient is advised to take a high dose of anti-biotic as prophylactic measure. Detoxifying the
surface of the implant is a great step towards ensuring the success of implants over a long-term
but mechanical detoxification isn’t enough to detoxify the surface of dental implant20,21. This
means that cleaning an implant is not a monotherapy but is a dual therapy. Chemical
decontamination of the dental implants is done with the objective to disrupt bacterial plaque
biofilm, detoxify cell components affecting growth on the implant surface, reducing bacterial
load by diluting to a level that will allow healing, with the goal to eliminate bleeding upon
probing, reduce or eliminate possible bacterial population on the implant and to stabilize bone
levels20. There is no reliable treatment to treat peri-implant disease but it doesn’t mean that
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current treatment doesn’t work22. Curettes are used to mechanically detoxify the surface of
dental implants, but it must be borne in the mind that these curettes must be softer than the
implant itself that is ideally made up of plastic, carbon fibres or gold curette. If the curette
damages the surface of the implant then it can damage the oxide layer causing an alteration in
the surface chemistry and the biocompatibility of the implant may be compromised. From a
chemical point of view, sodium hypochlorite (0.25%), a common household bleach can be used
to as an antiseptic. There has been an 80 fold decrease in biofilm endotoxin when compared
with water, it is present naturally in the neutrophils, macrophages & monocytes, there is no
histological effect on periodontal healing, it doesn’t corrode the implants and also is accepted as
a mouthwash by FDA23. A sequential therapy has been developed to effectively prevent the
instance of peri-implant mucositis, this therapy includes a combination of mechanical therapy,
anti-septic therapy, antibiotic therapy and surgical therapy24. The antibiotic treatment focusses
on reducing the bacterial population thus, in turn, reducing inflammation. The problem of
recolonization of implant surface is seen as soon as antibiotic therapy is stopped and true
osseointegration is not achieved25. Antibiotics like doxycycline, minocycline, metronidazole,
amoxicillin, etc. are most commonly used to treat peri-implant mucositis infections5,26,27.
Corsodyl gel 1%w/w is used to treat problems associated with gum like reddening, swelling,
bleeding etc. The Corsodyl gel contains chlorhexidine digluconate has a rapid mechanism of
action by acting in just 30 seconds killing all the bacteria and preventing the growth of bacteria
further by forming an anti-bacterial coating over teeth and gums which is protective in nature.
This anti-bacterial coating prevents plaque buildup for about 12 hours.
A-3 Doxycycline hyclate:
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Doxycycline hyclate is a salt form of doxycycline which is a second-generation tetracycline
and the only tetracycline which is eliminated from the body via both urine and faeces. Because of
its superior pharmacokinetics and a safer profile as compared to other tetracyclines, it is widely
used in the treatment of peri-implant mucositis and other bacterial infections in general.

Molecular structure of Doxycycline hyclate
Empirical Formula: (C22H24N2O8•HCI)2•C2H6O•H2O
Doxycycline is available in the form of 75mg and 100 mg delayed-release tablets and also
as 100mg and 200mg capsules. Doxycycline exhibits its bacteriostatic effects by inhibiting protein
synthesis by binding to the bacterial ribosomes thus, preventing the connection between aminoacyl t-RNA and 30s ribosomal subunit28. The bioavailability of doxycycline lies between 95% to
100%. Doxycycline shows a plasma protein binding of about 80% to 90%29. Doxycycline doesn’t
undergo metabolic transformation in the body and is excreted as it is in urine, faeces 29. The
partition coefficient of doxycycline is 0.6329. Doxycycline is a lipophilic molecule and shows
excellent tissue distribution29.Doxycycline shows its antibacterial effect by binding to 30S
ribosomal subunit and thereby preventing protein synthesis by the bacteria. The most common
side effects seen are nausea, vomiting, diarrhea and other effects may include difficulty in
swallowing, teeth staining, change in the amount of urine, rapid clearance and metabolism and
6

intracranial hypertension28,30. Intracranial hypertension may lead to sudden loss of vision, blurred
vision and severe headache.

A.4 The hydrophobic polymers used to provide a sustained release of Doxycycline hyclate:
A.4.1 Poly-Lactic glycolic acid (PLGA):

PLGA is a biodegradable and a biocompatible polymer having a wide range of biomedical
and Pharmaceutical applications. PLGA is synthesized from two monomers namely Polylactic acid
(PLA) and Polyglycolic acid (PGA). The ratio of Poly-lactic and poly-glycolic acid can be
changed to control the Physiochemical and pharmacokinetic properties of PLGA. Poly-lactic acid
is more hydrophobic than Polyglycolic acid because of the presence of methyl side groups31. Thus,
if the presence of polylactic acid is higher than poly-glycolic acid, it makes PLGA a hydrophobic
molecule and vice versa. A higher proportion of Poly-lactic acid makes PLGA more hydrophobic
thereby slowing down the degradation rate of PLGA. Properties like the ratio of Lactide: Glycolide,
initial molecular weight as well as storage conditions influence the physical properties of PLGA31.
A dose-dependent and a non-linear profile is followed by PLGA in its pharmacokinetic and bio
distribution profile31. PLGA is insoluble in water but freely soluble in organic solvents like
methylene chloride, toluene, acetic anhydride etc.
A.4.2 Polycaprolactone:
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Polycaprolactone is a biodegradable aliphatic polyester synthesized by ring opening
polymerization of ε-Caprolactone, having a wide range of pharmaceutical and biomedical
applications. Polycaprolactone shows strong mechanical properties, slower degradation rates as
well as poor cellular adhesion. The structural configuration of polycaprolactone determines its
degradation rate32. Polycaprolactone based root canal filling under the trade name “Resilon” is
being actively marketed and has many marked advantages in being biodegradable and non-toxic.

A.5 Layer by layer delivery of doxycycline hyclate for the prevention of peri-implant
mucositis:
The layer by layer local delivery of doxycycline is a type of surface modification which
has proven to be efficacious and therapeutically viable option9,33. With this method, a sustained
delivery of doxycycline hyclate has been achieved. The polymer combination primarily used was
chitosan and hyaluronic acid on account of their charge difference as well as their biocompatibility
with the human body9. Hyaluronic acid is an anionic, nonsulfated glycosaminoglycan found in
various tissues throughout the human body34. A healthy human body possesses about 10 to 100
grams of hyaluronic acid out of which about 33% is synthesized and eliminated on a daily basis34,35.
The process of wound healing is promoted by hyaluronic acid. A wounded tissue produces
hyaluronic acid in a higher quantity than normal36. Hyaluronic acid has a very short half-life of
about 2 to 6 minutes and is quickly removed from circulation by the human body35. Hyaluronic
8

acid is excreted via lungs, hepatic elimination as well as kidney and the gastrointestinal tract with
pulmonary and hepatic elimination dominating the excretion pathway35. Chitosan is a linear
polycationic natural polysaccharide which is derived from chitin37. Chitosan has been used in
various drug delivery platforms on account of its biocompatibility, non-toxicity, mucoadhesive,
biodegradability as well as it does not elicit an antigenic response from the human body28,37. It is
hypothesized that low molecular weight chitosan inhibits bacterial DNA transcription as well as
mRNA synthesis by traversing bacterial cell wall and binding to the bacterial DNA37,38. It has been
proved that gram-negative bacteria interact to a larger extent with low molecular weight chitosan
as compared to gram-positive bacteria on account of their higher hydrophilicity and negative
charge on the cell surface37. Low pH favors binding of chitosan to the bacterial cell wall as well
as enhances the polycationic nature of chitosan37,39. Lowering of molecular weight of chitosan
improves the selectivity of chitosan towards gram negative bacteria as well as the activity of grampositive bacteria is reduced considerably37.
Thus, the objective of the present study was to develop a layer by layer antibacterial and
anti-inflammatory coating loaded with doxycycline hyclate over the surface of titanium implants
using chitosan, hyaluronic acid, polycaprolactone and PLGA in a layer by layer technique. We
hypothesize that the layer by layer coating over the titanium implants will sustain release of
doxycycline hyclate over a longer period of time and in turn, will reduce the rate and extent of
bacterial biofilm formation over the implant surface.
A.6 Dental implants:
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Figure.1 Components of dental implant40
The research into the development of dental implants has risen tremendously in the past
few years41. The main purpose of using dental implants is to promote osseointegration of the teeth
with the gum cavity5. Osseointegration is a process by which, the implant locks and attaches itself
to the bone in the gum thus forming a strong anchor between the artificial tooth and the bone5.
Dental implants have a very high success rate but the chance of infection due to bacteria especially
gram-negative already present in the hard and soft tissue of the oral cavity is also high which can
lead to failure of therapy5,42. The risks and failure of dental implant surgery can be broadly be
classified into three broad categories which are first during surgery (excessive bleeding, nerve
damage), secondly after 6 months of surgery (infection or failure to Osseo integrate) and finally
the long-term factors which include peri-implant mucositis, peri implant-mucositis or mechanical
failures43–45. It has been seen that through surface modification of dental implants, the success of
implant therapy has been improved the following thesis will educate its readers on various aspects
of dental implants like its history, its clinical use, and the properties of dental implants.

10

A.7 Types of dental implants:
American dental association recommends two types of dental implants (Endosseous
&Subperiosteal) for safe use but there are three different types of dental implants present in the
market46,47.
1) Transosteal implants: These kinds of implants are available in the market in two different forms
namely U-shaped frame form or metallic pin form. When placed in the mouth, they pass
through both jawbone and gum cavity47.
2) Endosseous implants: These kinds of implants are available in the market in the form of
cylinder, blade or screw shape and are made up of primarily of titanium, zirconium and its
alloys47. The site of implantation of this type of implant is in the jaw bone and deeper the bone
in the mandible and maxilla, longer the implant will be.
3) Subperiosteal implants: This type of implant is attached between the jaw bone and the gum
tissue47. Subperiosteal implant comprise of a metallic framework47.

A.8 Influence of surface properties in the long-term success of dental implant-based
therapy:
The surface properties of the dental implant play a key role in the long-term success of
implant-based treatment. Surface properties like surface topography, surface wettability, surface
free energy have a significant impact on cellular adhesion, differentiation, spreading as well as the
production of local mediators of inflammation48–52. Surface properties determine the rate and the
extent of osseointegration of dental implants53. Biomaterials like dental implants are often in
contact with biological fluids and, there lies a relative movement between the solid and liquid
phases, this movement is referred to as “Dynamic Wetting”48. Surface properties have a
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significant impact on the interfacial reactions occurring between the implant surface and
physiological fluids as well as bone formation in vivo48,54,55 . The initial bio response to the
implanted dental implant depends upon the surface micro and nano topographical properties along
with the surface wettability48. The following surface properties influence the clinical success of
dental implant-based therapy.
A.8.1 Surface topography:
The microscopic and macroscopic properties of dental implants are referred to as surface
topography56.The cellular response of the human body to the dental implant depends upon the
surface topography of the dental implant 57 58 59 60. In cases where there is no adequate bone
at the site of implantation, those dental implants can be used whose surface characteristics have
adequately been optimized. The optimization of the surface of dental implants is done through
various surface treatments for rapid and long-lasting osseointegration

57 61

. The terms roughness

and topography can be used interchangeably with each other. Dental implants with adequate
roughness may improve the bone to implant contact, increase the torque removal force and also
has an impact on the primary stability of implants

56,62

. Since surface topography of the implant

is primarily responsible for the bone to implant contact, it has to be modified56. The surface of the
dental implant can either be made porous or through surface modification made more
hydrophilic56,63. Implant surface roughness can broadly be divided into three main categories
mainly macro, micro and nano roughness56. By appropriately adjusting the micro-roughness of the
dental implant, the long-term success of dental implant has been noted56,62. The rate of
osseointegeration of the dental implant in the oral cavity is determined by adsorption of proteins
and adhesion of osteoblastic cells over the surface of the dental implants56,64. The proliferation and
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differentiation of osteoblastic cells are largely affected by the nano-topography of the dental
implants65.

A.8.2 Surface Wettability:
Surface wettability is an important property associated with titanium oxide-based dental
implants66. Surface wettability is also used interchangeably with the terms hydrophilicity and
hydrophobicity53. Hydrophilic surfaces are superior to hydrophobic surfaces in terms of interaction
with biological fluids, cells and tissues thus ensuring better success rates of implant therapy53,67.
Most of the implants that are being marketed are hydrophobic in nature 66,68. The surface roughness
of the dental implants is also a factor that imparts hydrophobic character to the implants69. The
surface wettability of dental implants is quantified in terms of contact angle, which is the angle
between the tangent line to a liquid drop’s surface at the three- phase boundary and the horizontal
solid’s surface66. It has been observed that the success of dental implants is associated with
wetting of the implants and so to improve the process of wetting, the surface tension of implants
has to be increased70. The phenomenon of wetting is influenced by the energy of the solid surface
and that of the surface tension of the liquid58,70–72. Solid surfaces having high energy coupled with
liquids having low surface tension favors the process of wetting70. During the process of wetting,
the total energy of the system is reduced until it reaches an equilibrium stage also called
“Metastable equilibrium stage”68. Surfaces with wetting tension more than 30 mN m−1 are
generally classified as hydrophobic whereas those with a surface tension less than 30 mN m−1 are
classified as hydrophilic in nature48. Water because of its ability to form hydrogen bonds, has a
high surface tension of 73 mN m−1 68. Phosphate buffer has a surface tension of 69.5 mN m−1. The
surface tension of blood is 52 mN m− 1 which is further lower than water 68,73. The surface tension
of saliva lies between the range of 53.4 mN m−1 to 63.2 mN m−1 68,73,74.
13

Implant tissue interaction and osseointegration of the implant is affected by the
hydrophilicity of the surface of the implant as well as the surface composition of the dental
implant53. Hydrophilic surfaces interact to a larger extent with biological fluids, cells and tissues
as compared to hydrophobic surfaces53. It has been seen that the hydrophilization of the surface of
dental implants, improves the initial blood contact, promotes wound healing and thus, in turn,
promotes the overall process of osseointegration48.

A.8.3 Surface Charge:
The aspect of surface charge influences the way in which cells adhere to the implant surface
as well as other activities necessary for proper osseointegration 75. The surface if titanium-based
dental implants have an overall positive charge which makes it ideal for adhesion of negatively
charged cells to the surface of the implants76. Layer by Layer surface treatment of dental implants
alters the surface charge of dental implants by coating oppositely charged polymers over each
other based on the principle of ionic gelation so as to mimic the natural processes involved in
osseointegration.

A.8.4 Surface Chemistry:
Protein adsorption and the consequent cellular adhesion and proliferation is greatly affected
by the surface chemistry of the dental implants75. The carbon nanotubes present on the surface of
dental implants have a positive impact on cellular division and the subsequent proliferation which
in turn is necessary for osseointegeration75,77–80. Fibronectin adsorption, endothelial cell adsorption
and growth as well as corneal cell migration is highly influenced by variations in the surface
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chemistry of dental implants76,81,82. The surface chemistry of dental implants can be characterized
using X-ray photoelectron spectroscopy (XPS), a method which analyzes the chemical
composition of different groups on the dental implants83.

A.8.5 Surface Energy:
The process of osteogenesis is regulated by the surface free energy of the dental implants83.
Surface properties such as chemical composition of the surface, surface charge, surface microtopography have an impact on the surface energy

53

. Currently available dental implants in the

market are hydrophobic in nature on account of their surface roughness69.Contamination in any
form causes a reduction in the surface free energy of the dental implants83,84. Surface free energy
has a profound effect on protein adsorption process which in turn influences the cellular response
to the injected dental implant85. The surface energy is reduced when contaminants combine
strongly with the dental implants48. Thus, a strong emphasis has to be placed on maintaining
cleanliness of dental implants during handling and also during storage. Initial stages of tissue
healing after implant surgery is largely affected by the surface energy as well as the cleanliness of
the dental implants48,86. The critical polar portion (yp) and surface tension are ideal parameters that
indicate the surface free energy of the implants and the presence of organic contaminants on the
sample86. A lowering of surface tension intercept and a polar portion of the implant indicates the
presence of organic contaminants and reduction in the surface energy of the implants and vice
versa86. The implants thus have to be sterilized in such a way that there is no significant reduction
in the surface energy. Methods like dry heat sterilization have no effect on the surface energy of
the implants whereas, on the other hand, UV treatment resulted into the elevation of the surface
energy of the dental implants with a higher disposition for biological reactivity resulting into
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cellular adhesion and successful implant fixation86. The structural arrangement of proteins and the
adsorption of proteins on the surface of dental implants is also influenced by the surface energy of
dental implants53.

A.9 The oral environment surrounding the dental implant:
A.9.1 Saliva:
The dental implants get coated with salivary components as soon as the implant it fixed at
it sire in the oral cavity 87. Saliva provides the necessary proteins and other nutrients necessary for
bacterial growth over the implant surface to support the formation of bacterial biofilm and bacterial
metabolism87–89. The physio-chemical and surface properties of the implant changes because the
continuous saliva movement over the implant surface thus forming a coat made up of saliva. This
coat facilitates bacterial adhesion by forming specific receptors which finally promote bacterial
adhesion to the implant surface87. The presence of salivary esterase’s like albumin, alpha-amylase
etc. are known to degrade the resins of the dental implants

87,90

. The hydrolytic activity of these

esterase’s is known to be potentiated by the presence of cariogenic microbes present in the oral
cavity87,91.
A.9.2 Proteins:
The initial attachment of bacteria to the titanium surface is dictated by the ions and proteins
derived from blood76. Adhesion proteins like fibrinogen, fibronectin, vitronectin, Von
Willebrand’s factor strongly influence the initial interaction of the implant surface with biological
fluids, tissues and bone76 . The adhesion of proteins to the surface of the implants is strongly
affected by the adsorbed proteins76. The amount of cells adsorbed onto the surface of the implant
is related to the amount of protein adsorbed76.
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A.10 The process of biofilm formation:
The process of biofilm formation is a highly complicated and multi-stage process during
which micro-organism transforms to a sessile growth form from planktonic growth form92,93.
Specific genes are implicated in the formation and subsequent establishment of biofilm on the
surface of dental implant92–94. The host defense mechanisms, as well as antibiotic therapies, offer
little to no therapeutic outcome against bacterial biofilms5. The major source of nutrition and
energy for the biofilm is saliva with saliva itself being a high source of micro-organisms5. The
bacteria that attach to the surface of the dental implant, secrete chemicals like extracellular
polysaccharides coupled with some adhesion structures which facilitate the process of biofilm
formation5,95,96. The bacterial species responsible for biofilm formation communicate with each
other through a special mechanism called “Quorum Sensing”93,97. Quorum sensing directly
regulates the process of biofilm formation5,98. The process of biofilm formation begins within a
few hours as soon as an implant is placed in the oral cavity, a process which is further facilitated
by saliva and presence of food particles5. Biofilms are majorly composed up of water with
additional components like DNA, RNA, polysaccharides, proteins, enzymes as well as some
extracellular polymeric substances93. The reason why biofilms are resistant to everyday antibiotics
is that the biofilm-forming bacteria switch on certain genes which in turn get converted to resistant
phenotypes on account of changes in pH, osmolarity, nutrition, temperature etc.

93,99

. Secondary

metabolites are produced by the bacteria in the biofilm during the process of biofilm formation
which in turn play the role of a signaling molecule to further promote the process of biofilm
formation93. The process of formation can be summarized briefly into the following steps a)
Attachment to surface b) Micro-colony formation c) Final maturation and detachment5,100. The
initial attachment phase is a reversible one wherein a solid-liquid interface exists between the
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micro-organism and the implant surface5,93. A rough, hydrophilic environment provides an ideal
environment for biofilm formation93. Biofilm formation is potentiated by the presence of special
cellular structures of bacteria like flagella, pili, fimbriae, polysaccharides

93,101

. The subsequent

step of micro-colony formation takes place after the attachment is successful, and a series of
chemical signals promote biofilm growth and maturation93,102. In the maturation phase, water
channels are formed within the biofilm matrix, which promotes the growth of biofilm by removing
waste materials from the biofilm matrix and at the same time providing essential nutrients for
sustaining the biofilm93,103. The final phase of detachment can be due to two reasons firstly as a
part of the natural process and secondly due to mechanical stress within the biofilm which makes
the bacteria leave the biofilm matrix to mature and multiply elsewhere93,100. As soon as the bacteria
are ejected from the matrix of the biofilm, they cease the production of enzymes and other
polysaccharides93. The cells in the biofilm inherit certain properties from the biofilm-like antibiotic
resistance, multiplication etc93 which make traditional antibiotic therapy useless on account of
poor penetration of antibiotics into the biofilm matrix93.

Figure.2. Process of biofilm formation
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A.11 Hypothesis & Specific Aims:
We hypothesize that by coating the dental implant in a layer by layer fashion with a
combination of polymer, we can achieve a sustained delivery of doxycycline hyclate over a period
of two to three weeks and at the same time ensure that the process of osseointegration progresses
smoothly without bacterial infection hindering it.
Aim 1: To achieve a drug concentration of higher than 10 µg/ml every day, the minimum
inhibitory concentration of doxycycline hyclate required to inhibit the growth of gramnegative anaerobic bacteria.
In order to achieve this, different amount of drug concentrations was loaded in the
chitosan solution ranging from 375 mg to 600 mg. The release was characterized by conducting
in vitro release studies. The solubility of doxycycline hyclate was also analyzed in water during
this study.
Aim 2: To find the optimum concentration of individual polymers for coating the dental
implants.
A number of concentrations were studied for ranging from 1% to 6%, in the end, 4%
concentration of hyaluronic acid, chitosan was chosen because the viscosity was neither too high
nor too low. A concentration of 4% was chosen for PLGA in methylene chloride and a
concentration of 5% polycaprolactone in methylene chloride was chosen based on the similar
criteria of viscosity and solubility.
Aim 3: To evaluate the hydrophilic/hydrophobic nature of coated as well as uncoated
titanium disc
This study was conducted because hydrophilic implants have a higher success rate when
compared with hydrophobic implants. As the hydrophilic character increases, the interaction with
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blood, tissues, bones and other biological fluids also increases. Thus, a contact angle of smaller
than 90 º indicates that the implants are hydrophilic in nature.
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CHAPTER 2
MATERIALS AND METHODS
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Titanium implants were obtained from Branemark System of different sizes in
collaboration with the University of Tennessee Health Sciences Centre. Low molecular weight
water-soluble chitosan was obtained from Carbosynth Limited. Polycaprolactone having
molecular weight 25,000 was purchased from Polysciences Limited. Doxycycline hyclate
(>/98%) HPLC grade was purchased from Sigma-Aldrich life sciences. Hyaluronic acid
sodium salt- low molecular weight 40,000 to 50,000 was purchased from Carbosynth Limited.
Titanium disc of medical grade was obtained from Sigma Aldrich. PLGA (50:50) was
obtained from Durect Corporation, Cupertino, California.
B.1 Fabrication of multi-layer polymer coatings onto the titanium implant surface:
The implants were coated keeping in mind the aspect of surface charge. The titaniumbased implants have an overall positive charge so the obvious layer of choice is 4% hyaluronic
acid, a polyanionic polymer. The charge difference promotes adhesion of hyaluronic acid to
the surface of the dental implant. The coating cycle had to be optimized in order to ensure
proper and efficient coating of the implants. Soon after coating the surface of the implants
with hyaluronic acid, the polymer coating was dried with a cool air using an air blower so as to
ensure that maximum amount of polymer got dried before proceeding to the step of vacuum
drying. Air drying was performed for a longer time so as to ensure that vacuum drying did not
cause any cracking of the polymer film. Vacuum drying was done soon after air drying for 4
to 6 hours continuously to remove all the solvent molecules from the polymer coat. This
process was repeated again in a cyclic manner again with chitosan 4% solution.
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B.2 Preparing Chitosan (LMWWS)-Doxycycline hyclate complex:
Low molecular weight water-soluble chitosan was used for the preparation of a 4% solution
of the polymer in water. Dissolution of the polymer was achieved through mild heating and vortex
mixing. To this 4% polymer solution, 375 mg doxycycline hyclate was added and the solution was
subjected to mixing at a speed of 50rpm on a magnetic stirrer for 30 minutes. The resulting solution
was a clear yellow colored solution which has to be stored under refrigeration.

B.3 Scanning Electron Microscopy:
The nanotube dimensions were verified using Field Emission Scanning Electron
Microscopy (FESEM) (JEOL-JSM 6320F). The scanning electron microscope (SEM 15 kV,
Cambridge 360) was used to characterize the polymer coated dental implants in terms of atomic
composition, coating thickness and morphology. Implant surface. Implant surface morphology
alterations were identified by SEM (Carl Zeiss EVO 40, Peabody, Massachusetts, USA) at the
UTHSC College of Dentistry Laboratory of Bioscience Research, Memphis, Tennessee, USA. The
implants were secured to the STEM sample holders and they were fully inspected by the SEM at
20 kV at 50x magnification for damage inspection. SEM analysis was conducted to verify the
success of the coating procedure. Elemental analysis was also performed along with SEM analysis
to check the levels of individual elements before and after the coating process.

B.4 In-vitro drug release studies:
The release studies were carried out in 2 ml Eppendorf tubes in a release medium consisting
of phosphate buffer having pH 7.4, 6 and 5 respectively. The release studies were done to mimic
the pH of the biological fluids present in the oral cavity like saliva and blood whose pH is 6.8 and
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7.4 respectively. The Eppendorf tubes were then suspended in a water shaker bath (Precision,
ThermoFisher, USA) at a temperature of 37 degree Celsius and at a shaking speed of 80rpm to
mimic physiological conditions. On the first day, the release medium was replaced after every hour
to check for burst release of doxycycline from the polymer matrix. The release medium was
replaced on a daily basis to plot the release profile curve. The released drug was analyzed using
UV spectrophotometry at 353 nm.

B.5 UV Spectrophotometry:
UV spectrophotometry was used for drug release study. The blank used for this study was
phosphate buffer. The calibration curve was plotted at 353 nm and the UV measurements were
carried out at 353nm. For the preparation of the calibration curve, a 1mg/ml solution of
doxycycline hyclate was prepared by dissolving 50mg doxycycline hyclate in 50 ml water.
B.6 pH meter:
For preparing buffers of different pH, Cole-Parmer P-200 pH meter with electrode holder
was used. The instrument has to be calibrated every day before it is used to prevent errors from
past interfering with current results. Standard solutions of known pH were used for calibration of
the equipment.
B.7 In-vitro release of doxycycline hyclate from polymer matrix:
The release studies were conducted on 25 polymer and drug-coated dental implants with
the release medium being phosphate buffer of different pH at a physiological temperature of 37degree Celsius in order to assess the effect of pH on the release of doxycycline from the polymer
matrix.
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B.8 MTT Assay:
The metabolic activity of living cells was evaluated using MTT (3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide) tetrazolium assay. Various reductase enzymes like
mitochondrial reductase, NAPH reductase etc. reduce MTT to a purple insoluble compound called
as Formazan. The insoluble formazan is solubilized using acidified ethanol, sodium dimethyl
sulfoxide or sodium dodecyl sulphate in dilute hydrochloric acid. The cytotoxicity of polymer
coated only as well as polymer & doxycycline hyclate coated dental implants was evaluated by
means of the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay. Normal
gingival fibroblasts were cultured and plated (1x105 cells) in a 6 well dish.

B.9 Differential Scanning Calorimetry:
Differential scanning calorimetry (TA Instruments, Discovery Series, Delaware, USA) was
used to assess the thermal properties and compatibility of polymers and doxycycline. Samples
weighing between 5 to 10 mg were hermetically sealed in an aluminum pan and heated at a rate
of 10º Celsius per minute from 25 º to 150 º Celsius. Ultra-pure nitrogen was used as the purge gas
at a flow rate of 50 ml/min.
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B.10 Contact angle measurement:
Contact angle measurement was used to determine the effect of coating on the wetting
behavior of titanium surface. Attension Theta equipment was used for measurement of contact
angle (Biolin Scientific, USA). The equipment has to be calibrated prior to use. The YoungLaplace fitting mode was used for calculating the contact angle. OneAttension software was used
to measure and calculate the contact angle.

B.11.Formulation optimization:
Formulation

Hyaluronic

Chitosan

Doxycycline

acid %

(LMWWS)

hyclate %

Result

%
F1

1%

1%

600mg

low viscosity of hyaluronic acid
and

chitosan

solution,

a

flocculated solution of chitosandoxycycline hyclate was
obtained.
F2

2%

2%

500mg

Low viscosity of hyaluronic
acid and chitosan, chitosandoxycycline hyclate complex
shows flocculation in spite of
rapid vortex mixing and
heating.
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F3

3%

3%

450mg

Low viscosity of hyaluronic
acid and chitosan, chitosandoxycycline complex shows
some flocculation.

F4

4%

4%

375mg

Hyaluronic acid and chitosan
are free-flowing and the
chitosan-doxycycline complex
doesn’t show any flocculation
of doxycycline hyclate particles.

F5

5%

5%

375mg

The viscosity of hyaluronic acid
and chitosan solution increases,
problems were encountered in
the coating process.

F6

6%

6%

375mg

Very high viscosity, unable to
proceed with coating, coating
process becomes uncontrollable.

B.11.1 Optimization of the polymer concentration:
PLGA%

Result for

Polycaprolactone%

Result for polycaprolactone

PLGA
2%

Low

2%

viscosity,

Low viscosity, free-flowing
solution, thin coating achieved.

free-flowing,
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coating
thickness was
compromised.
3%

Low

3%

Viscosity increased but still the

viscosity,

viscosity was low which affected

free-flowing,

the thickness and the coating

coating

process.

thickness was
compromised.
4%

Viscosity was

4%

Viscosity increased further but

neither too

still was low which affected the

low nor too

coating thickness and process.

high, was
appropriate
for coating
process to
proceed.
5%

Viscosity

5%

Optimum viscosity achieved,

increased

neither too free flowing nor to

giving a gel-

gel-like, appropriate for the

like

coating process.

consistency,

28

not well for
coating.
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CHAPTER 3
RESULTS AND DISCUSSION
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C.1 Scanning electron microscopy:
The Scanning electron microscopy samples were divided into three groups
namely the uncoated (blank), the second group comprising of samples made up of hyaluronic
acid, chitosan (LMWWS) and doxycycline hyclate, the third group comprising of samples
made up of hyaluronic acid, chitosan (LMWWS) and PLGA. The levels of titanium were
checked in different groups and it can be said that for uncoated titanium implants, the levels of
titanium are higher when compared to implants coated with polymer. As the implants are
coated with a mixture of polymers, the level of titanium reduces whereas the level of organic
content increases concurrently.
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Figure.3 Uncoated titanium dental implant at 1X magnification
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Figure.4 Elemental analysis of spectrum 13 of uncoated titanium implants
Figure.4 represents spectrum 13, from the spectrum it can be inferred that the level of
titanium is higher than the organic content present on the uncoated dental implant.
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Carbon

Figure.5 Comparison of %weight of each element of uncoated dental implant
From figure.5, it can be inferred that the % weight of titanium is higher than the % weight
of organic content over uncoated dental implants. This proves that the implants have not been
coated with any polymers or the active pharmaceutical ingredient.

Figure.6 Titanium implant coated with layers of hyaluronic acid, chitosan (LMWWS) and
doxycycline hyclate.
Figure.6. represents implant coated with polymer layer of hyaluronic acid, chitosan
(LMWWS) and doxycycline hyclate. There are four zones that have been focused upon in this
region denoted as spectrum 15,16,17,18,19,20.
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Figure.7 Elemental analysis of spectrum 17 of implant coated with layers of hyaluronic
acid, chitosan (LMWWS) and doxycycline hyclate.
Figure.7 represents spectrum 17 from figure.6, the spectrum indicates that the organic
content of layer by layer coated implants is way higher than the titanium content of the dental
implant thus, indicating that coating was successful.

35

Elemental Analysis of coated Dental Implants
70

%weight of each element

60
50
40
30
20
10
0
Titanium
-10

Oxygen

Carbon

Elements

Figure.8 Comparison of %weight of each element of coated dental implants
From figure.8, it can be seen that the % weight of carbon has increased but the % weight
of oxygen still remained the same as uncoated dental implants. The % weight titanium have
reduced for coated implants. Thus, it can be said that coating was successful on account of
reduction in the % weight levels of titanium and subsequent increase in the levels of carbon.

C.2 Contact angle measurement:
The samples were titanium discs divided into two groups to check out for a difference in
the contact angle between uncoated and coated titanium disc. The coated discs were again divided
into three groups, each group containing three titanium discs (n=3) namely: Group A is the control,
Group B consisting of Hyaluronic acid and chitosan, Group C consisting of Hyaluronic acid,
chitosan and PLGA and the final group, Group D consisting of Hyaluronic acid, Chitosan and
Polycaprolactone. The samples were placed on a magnetic holder which is called as “sample stage”.
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Each sample was analyzed for a period of 100 seconds in order to allow for the water droplet to
stabilize over that period. The water droplet stabilizes over a period of 60 to 80 seconds.

(A)

(B)

(C)

(D)

Figure.9 Contact angle images of different formulations
Figure (A) represents an uncoated titanium disc (Control), the mean contact angle was
found to be 34.11 º which shows that the titanium disc surface is hydrophilic in nature.
Figure (B) represents the coated titanium disc. The titanium disc was coated with a polymer
combination of Hyaluronic acid, Chitosan and Doxycycline hyclate. The mean contact angle
dropped from 34.11 º to 16.83 º indicating an increase in the hydrophilicity imparted by the
polymer combination.
Figure (C) represents titanium disc coated with a polymer combination of hyaluronic acid,
Chitosan, Doxycycline Hyclate and PLGA. The mean contact angle rose from 34.11 º to 62.16 º.
This increase in contact angle indicates that PLGA as a polymer is imparting hydrophobicity to
the formulation. In spite of increase in the contact angle, the final formulation still is hydrophilic
since the contact angle is below 90 º.
Figure (D) represents titanium disc coated with a polymer combination of hyaluronic acid,
Chitosan, Doxycycline hyclate and Polycaprolactone. The mean contact angle rose from 34.11 º
to 67 º. The increase in the contact angle indicates that Polycaprolactone as a polymer is imparting
hydrophobicity to the final formulation. In spite of the increase in the contact angle, the final
formulation is still hydrophilic in nature since the contact angle is below 90 º.
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Figure.10 Comparison of the contact angle of different formulations (n=3)
From figure.10, it can be seen that polycaprolactone and PLGA coated formulations
showed a higher degree of hydrophobicity as compared to the control (uncoated disc) and the
hyaluronic acid and chitosan coated discs.
Hydrophobic polymers are imparting a hydrophobic character to the entire formulation.
The hydrophobicity of polycaprolactone is higher when compared with other formulations in this
study. Although, the hydrophobic polymers are increasing the contact angle by a factor of about
50 º (±10 º), still the formulations are hydrophilic in nature because contact angle is less than 90 º.
A hydrophilic formulation is desired in this study because a hydrophilic implant interacts to a
larger extent with the biological fluids, tissues and the process of osseointegeration will be initiated
at the earliest.
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C.3 Differential Scanning Calorimetry:

Figure.11 Differential Scanning Calorimetry of API and Polymers
The differential scanning studies were conducted on pure drug and polymer. The results of
the study are shown in the figure.11. From the thermogram, it can be reported that
polycaprolactone shows a melting point of 60º Celsius. Chitosan shows a melting temperature of
220º Celsius but being amorphous in nature, the melting point is not sharp at 220 º Celsius, chitosan
undergoes degradation rather than melting. Doxycycline hyclate shows melting point around 230º
Celsius. Hyaluronic acid being amorphous in nature, does not show a clear melting point.
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Figure.12 Differential scanning thermogram of different formulations.
The red line in figure 12. represents the thermogram of the polymer and API combination
of hyaluronic acid, chitosan (LMWWS), doxycycline hyclate and PLGA.The formulation shows
a sharp endothermic peak at 195º Celsius indicating melting point of the formulation.
The blue line in figure 12. is the thermogram of polymer combination of hyaluronic acid, chitosan
(LMWWS), doxycycline hyclate and polycaprolactone. The polymer combination shows a sharp
endothermic peak at 55º Celsius which indicates the melting point of the melting point of the
formulation.
The green line represents the thermogram of hyaluronic acid, chitosan (LMWWS) and
doxycycline hyclate. The formulation shoes a sharp endothermic peak at 100º Celsius which
indicates the melting point of the formulation.
There is a shift in the endothermic peaks of different formulations on account of various
charge- based I interactions between different polymers of the formulation. The outermost layer
of the
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formulation determines to a larger extent the melting behavior of the entire formulation as seen in
the thermogram.

C.4 In-vitro release study:
The implants were divided into five groups based on the polymer combination with which
the implants were coated with:
C.4.1 Implants coated only with Doxycycline:
The implants were coated only with only doxycycline hyclate to assess the release profile
pattern. It was found out that the release was rapid and swift with the release lasting for only about
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Figure.13 Release study of implants coated with doxycycline hyclate at pH 6.0
As shown in Figure.13, it can be inferred that the release progressively increased until the
12th hour and after that appeared to reach a plateau indicating that 100% drug was released from
the polymer matrix by 18th hour. The total amount of drug released is around 90 mg (90,000µg) in
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a span of 18 hours. It can be seen that at a lower pH, a higher amount of doxycycline hyclate is
released from into the release medium.
From the percentage release profile, it can be inferred that more than 50% of doxycycline
hyclate has been released into the release medium by the 5th hour and by the 18th hour, a plateau is
seen indicating a 100% release into the release medium.
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Figure.16 Release study of implants coated only with doxycycline hyclate at pH 7.4
From figure.16, it can be inferred that the release progressively increased up until the 11th
hour and appears to have reached a plateau by the 18th hour indicating 100% drug release from the
polymer matrix into the release medium. The total amount of drug released is around 38 mg over
a span of 18 hours.
About 50% of doxycycline hyclate has been released by the 8th hour and by the 14th hour,
it appears that a plateau has been reached.
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Comparing figure 15 and 16, we can say that at a lower pH, the amount of doxycycline
hyclate released is higher when compared with the amount of doxycycline hyclate released at an
elevated pH.
C.4.2 Implants coated with Hyaluronic acid, chitosan and doxycycline hyclate:
The implants were coated in an alternating layer by layer fashion with Hyaluronic acid and
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Figure.17 Release study of implants coated with hyaluronic acid, chitosan and doxycycline
hyclate at pH 7.4
It can be inferred from figure.17 that about 40 mg doxycycline hyclate has been released
from the polymer matrix into the release medium over the span of 8 days. The release progressively
increased up until the 6th day and after that appears to have reached a plateau by the 8th day
indicating 100% release of doxycycline hyclate from the polymer matrix.
From the percent release graph, it can be inferred that by the 3rd day, about 50%
doxycycline hyclate has been released from the polymer matrix of hyaluronic acid and chitosan.
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C.4.3 Implant coated with Hyaluronic acid, Chitosan, PLGA:
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Figure.18. Release study of implant coated with polymer combination of hyaluronic acid,
chitosan, doxycycline and PLGA at pH 7.4
From figure.18, it can be inferred that the release increased progressively until the 9th day
and by the 11th day, a plateau appears to have reached indicating 100% release of doxycycline
hyclate into the release medium. The total amount of drug released is around 12 mg over a period
of 11 days.
From the percent release graph, it can be seen that by the 1st day, a burst release has taken
place which PLGA as a barrier polymer couldn’t control but soon after day 1, the release stabilized
and a sustained release of doxycycline hyclate can be seen over a span of 11 days.

44

30000

100
90
80
70

20000

60
15000

50
40

10000

Percent release

Cumulative release

25000

30
pH 5.0

5000

20

% release

10
0

0
0

2

4

6

8

10

12

Time (Days)

Figure.19 Release study of implant coated with hyaluronic acid, chitosan, doxycycline
hyclate and PLGA at pH 5.0
From figure.19, it can be inferred that the release continued to rise steadily until the 10th
day and by the 11th day, it appears to have reached a plateau indicating a 100% release of
doxycycline hyclate into the release medium. From the graph it can be inferred that 25 mg of
doxycycline hyclate has been released over a span of 11 days.
From the percent graph, it can be interpreted that within the 1st day, more than 50% of
doxycycline hyclate has been released from the polymer matrix into the release medium which is
the burst effect which is sufficient to kill any initial bacterial growth around the dental implant and
in the vicinity. The release stabilized after day 1 and a concentration higher than the minimum
inhibitory concentration has been achieved until day 11 after which, the amount of doxycycline
released falls below the minimum inhibitory concentration.
C.4.4 Alternating pH change release study:
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Figure.20 Alternating release study at pH 7.4 and 5.0
The main aim of this study was to evaluate the effect of change in pH on the release of
doxycycline hyclate from the polymer matrix used for coating the dental implant. The release study
was started with phosphate buffer of pH 7.4 and from figure.20, it can be seen that a burst release
by day 1. The release for the next three days took place in phosphate buffer of pH 7.4 but on day
5, the pH was replaced with same phosphate buffer but having a lower pH of 5.0 to assess the
impact of lowering of pH on the release of doxycycline hyclate. As expected, the release jumped
from 10.4 mg to 13.8 mg within a span of one day. The release ºsteadily rose until day 14 and
appears to have reached a plateau by day 16, indicating a 100% release of doxycycline hyclate into
the release medium.
C.4.5 Implants coated with hyaluronic acid, chitosan, doxycycline hyclate and
polycaprolactone:
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Figure.21 Release study of implant coated with Hyaluronic acid, Chitosan, Doxycycline
hyclate and Polycaprolactone
From figure.21, it can be inferred that about 16 mg doxycycline hyclate was released from
the polymer matrix into the release medium. A burst release can be seen on day 1 of about 8.5 mg
but soon after that, the release stabilizes and a sustained release is obtained over a period of 21
days.
On the 14th day, the release medium was changed from pH 7.4 to pH 5.0 to check out for
any change in the release profile pattern. It can be seen that a small spike in release can be seen on
day 15 which continues to rise until day 17 after which, the release profile shows a plateau
indicating 100% release from the polymer coating.
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Figure.22 Release study of implants coated with Hyaluronic acid, Chitosan, Doxycycline
hyclate and Polycaprolactone at pH 7.4
From figure.22, it can be inferred that the total amount of drug released was about 20 mg
which is higher than the amount of drug released at pH 7.4. The release continues to increase up
until day 11 but appears to reach a plateau by the 15th day. It can thus be interpreted that by day
20, 100 % doxycycline hyclate has been released into the release medium.
It can be inferred from the release profile that hydrophobic polymers namely
polycaprolactone and PLGA are providing a sustained release of doxycycline hyclate over an
extended period of time as compared with other formulations made up of hyaluronic acid &
chitosan and only doxycycline coated dental implants. The hydrophobic polymers provide a
sustained release by preventing the entry of water into the polymer matrix. The layer by layer
release system is sensitive to change in pH and as seen from the release profiles, lower pH
promotes a higher release of doxycycline hyclate into the release medium. The reason for this
behavior can be attributed to polymer and doxycycline hyclate behavior at different pH. At a lower
48

pH, the cationic nature of chitosan (LMWWS) is enhanced which causes the doxycycline hyclatechitosan complex to weaken causing the release of free doxycycline hyclate into the release
medium. A burst release is seen on account of swelling of polymer coating when placed in
phosphate buffer.

C.5 MTT Assay:
Cytotoxicity of polymer coated dental implants was evaluated by means of the MTT (3[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay. Normal gingival fibroblasts
were cultured and plated (1x105 cells) in a 6 well dish. Three implants from two experimental (100
nm diameter, 180 nm diameter DINS) and one control group were placed in individual wells
containing attached fibroblasts and incubated for three days. At the end of incubation period, the
implants were removed and the cell viability was determined by MTT cell proliferation assay.
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Figure.23 MTT cytotoxicity assay
The control shows a cell viability of 100% based on calculations using optical density. The
cell viability is about 94.89 % in the presence of polymer and doxycycline hyclate coated dental
implants. The cell viability is 92.49% in the presence of only polymer coated samples. The cell
viability in the presence of uncoated dental implants is 93.39%.
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The peri-dontal connective tissue contains a higher proportion of gingival fibroblasts cell
type. These gingival fibroblasts are involved in periodontal tissue repair as well as mediate the
inflammatory processes104. From the results of MTT assay, it can be interpreted that there is no
significant difference between the different groups. Both the polymer and drug as well as only
polymer coated implants are not cytotoxic towards human gingival fibroblasts. The cell viability
of all the groups apart from control is more than 90 %.
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CHAPTER 4
CONCLUSION

52

The layer by layer drug delivery system provides a sustained release of doxycycline
hyclate depending upon the polymer used as barrier to control the release. The hydrophobic
polymers provide a sustained release of the drug over a period ranging from up to 21 days,
providing a concentration of doxycycline hyclate higher than minimum inhibitory concentration
over that period. The layer by layer drug delivery system also shows sensitivity to change in pH
with lower pH promoting an increase in the total amount of drug released. All the formulations
are hydrophilic in nature which makes them ideal for ensuring a rapid osseointegeration and a
higher level of interaction with the biological fluids and tissues.
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